MAPT and Alzheimer disease: AD is a complex disease, and its treatment requires multiple approaches targeting the formation/clearance of Aβ and hyper-phosphorylated tau, supporting and stabilizing the remaining neuronal networks, and protecting the potentially sensitive mitochondria.